NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jaeger U
Medizinische Universität Wien - Vienna / Austria
Others
AD Scientific Index ID: 1391748
Medical university Vienna
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jaeger U's MOST POPULAR ARTICLES
1-)
Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphomaSJ Schuster, MR Bishop, CS Tam, EK Waller, P Borchmann, JP McGuirk, ...New England Journal of Medicine 380 (1), 45-56, 201924332019
2-)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by …M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ...The lancet oncology 7 (5), 379-391, 200624032006
3-)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialM Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ...The Lancet 376 (9747), 1164-1174, 201022472010
4-)
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemiaJC Byrd, JR Brown, S O\'Brien, JC Barrientos, NE Kay, NM Reddy, ...New England Journal of Medicine 371 (3), 213-223, 201419902014
5-)
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferationTJ McDonnell, N Deane, FM Platt, G Nunez, U Jaeger, JP McKearn, ...Cell 57 (1), 79-88, 198916201989
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept